Research & Development

Healthcare R&D teams can accelerate discovery, development, and validation with AI-driven insights and scalable data science—backed by deep medical and biotech expertise. Keep full IP control while leveraging flexible, high-impact support.

Healthcare R&D teams face increasing pressure to accelerate the discovery, development, and validation of new healthcare products and services while integrating cutting-edge AI and data-driven approaches. They need a flexible, expert partner who understands both the complexity of medical research and the power of data science.

DNAlytics’ R&D Support service empowers teams to leverage massive datasets, advanced algorithms, and scalable computing power—without the overhead of building in-house capabilities. Our service adapts to your specific project needs and workload fluctuations, ensuring seamless integration with your research timelines.

Unlike generalist AI and data science providers, DNAlytics brings deep domain expertise in healthcare and biotechnology, validated by our scientific track record. We offer a collaborative and IP-friendly approach, ensuring that all innovations remain fully owned by your organization. Whether you need support for biomarker discovery, clinical trial optimization, or AI-driven decision support, we provide the specialized expertise to drive your R&D success.

Let’s accelerate your next breakthrough—with the right data, the right models, and the right expertise.

Innovate in medical technology

In collaboration with multiple research centers and companies, we support the development of new technology for overcoming antimicrobial resistance. This highly multidisciplinary project involves clinical research, machine learning, software development and generative AI.

Create new medtech products !

Develop advanced therapies

Based on a genetic sequence of a protein of interest, we generate in sillico optimized sequence for the development of mRNA therapies. These optimized sequences have been proven to be actually capable of being produced in vitro.

Develop treatments faster with data sciences !

Develop new prognostic tools

Based on multiple cohorts of patients with oesophageal varices, we suported a team of medical researchers to identify a set of prognostic biomarkers, built a predictive model on these markers, and developed a prognostic score computation system (demo). This system led to multiple publications and allows for better liver graft scheduling.

Accelerate your clinical innovation!

Discretion required?

Most of our customers have strict confidentiality constraints. For most applications, IP also matters. That is why on multiple occasions, a part of our work consists in developing confidentiality- and IP-preserving applications integrating otherwise publicly available resources. You do not want to push your queries on AlphaFold or ChatGPT ? We can internalize a lot of different models and make them available locally for you.

Access recent models/databases without disclosing your research!

Data Sciences

From basic statistics to most advanced Generative AI and bioinformatics, we adopt the right level of technology for the right challenge. And we have GPUs.

Life Sciences

Access to life sciences resources such as a lot of different specific databases, datasets, technology platform data pipelines. Not to mention strong life sciences experience.

Software Dev

What use are data sciences if not implemented after design and validation? From prototyping to production-ready software, we deliver.

Regulatory

GMP, GCP, GDPR, AI Act, MDR, IVDR, 21CFRPart1, ... Share your constraints, and we'll make sure our work fits nicely into your roadmap.

Pushing data-driven innovation boundaries

We continue to innovate in data sciences applied to the healthcare industry. Our colleagues contribute to push the boundaries of scientific knowledge by publishing advances in data sciences and their innovative application to biotechnologies. Often hand in hand with our customers and partners.

Bioinformatics

Unraveling the links between pathogens and chronic diseases: A unified network approach, M. Bastin et al. To appear, 2025.

Medical Devices

Dominance of drug target mechanisms in Rheumatoid Arthritis. J. Paul et al.
Annals of Rheumatic Diseases 78, 2019.

Personalized Medicine

Immune Response Evolution in Peanut Epicutaneous Immunotherapy for Peanut-Allergic Children, M. Bastin et al. - European Journal of Allergy and Clin. Immuno., 2023.

Drug discovery

AI-Driven Drug Discovery (demo). C. Toussaint et al.
AIDD Workshop, OpenHub Louvain-la-Neuve, 2023.

Discover more publications